Sumatriptan (subcutaneous)
Treatment for Cluster Headache
Typical Dosage: 6 mg subcutaneous
Effectiveness
90%
Safety Score
68%
Clinical Trials
55
Participants
5.5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
6 mg subcutaneous
Time to Effect
5-10 minutes
Treatment Duration
As needed (acute)
Evidence Quality
HIGHNumber Needed to Treat (NNT)
2.5(Treat 2.5 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,700
Monitoring:$1,000
Side Effect Mgmt:$50
Total Annual:$3,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$3,667
Sumatriptan (subcutaneous) Outcomes
for Cluster Headache
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+75%
Common Side Effects
Injection site reaction
+15%
Chest discomfort
+4%
Dizziness
+3%
Nausea
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov